FMC has entered into a strategic collaboration with Novozymes, a world leader in biological solutions, to research, co-develop, and commercialize biological enzyme-based crop protection solutions for growers around the world.
Collaboration between the two companies will concentrate on enzyme-based biocontrol technology for the global fungicide and insecticide markets under a multi-year global agreement. The partnership will focus on developing solutions for controlling key soybean fungal diseases such as Asian Soybean Rust (ASR), in addition to combination products with FMC’s leading diamide insecticide technology for controlling key insect pests. The companies will combine their respective R&D capabilities with FMC serving as commercial partner and Novozymes as the manufacturing partner. The partnership will leverage Novozymes’ technology to date, and FMC will help expedite and improve the success rate in identifying innovative biological crop protection products by assessing multiple classes of enzymes at the company’s high throughput screening laboratory.
“We look forward to partnering with Novozymes in bringing enzymatic technology to the crop protection market,” said Mark Douglas, FMC president and chief executive officer. “FMC is committed to delivering differentiated biological products that provide growers with science-backed solutions to help sustainably manage crops, protect yields, and combat resistance. The use of enzymes in agriculture is an exciting new frontier for biologicals.”
“We see FMC as a great partner with strong scientific and commercial capabilities – and, importantly, a clear commitment to biological solutions,” says Ester Baiget Arnau, Novozymes’ president and chief executive officer. “Our partnership with FMC is part of our increased efforts to meet the need for sustainable pest control solutions for growers around the world. Together, we will develop innovative biological solutions for key market segments where FMC is an ideal commercial partner.”